 |
We are honored to announce that Laura Carpenter, CEO, is also Director at Large for the Arizona Pharmacy Association! |
U.S. Department of Health and Human Services News Release 202-690-6343media@hhs.govwww.hhs.gov/newsTwitter @SpoxHHS FOR IMMEDIATE RELEASEWednesday, August 19, 2020 HHS Expands Access to Childhood Vaccines during COVID-19 Pandemic The U.S. Department of Health and Human Services (HHS) issued a third amendment to…
Read More HHS Expands Access to Childhood Vaccines During COVID-19 Pandemic
Everywhere you turn, there seems to be a new set of laws looking to regulate the practices and goals of Pharmacy Benefit Managers (PBMs). While for the past decade, much of this legislation has trickled in on a state-by-state basis, Congress took the hint and jumped on the bandwagon in October of 2018, passing the Patient Right to Know Drug Prices Act into law.
It’s hard to ignore the fact that we are in the midst of a nationwide opioid epidemic. In fact, a nationwide public health emergency was declared on October 26, 2017 as a means to combat the opioid abuse crisis.
About DXM abuse behavior and management.
Of course, the biochemistry definition paints a bit of a nicer picture describing it as a substance that interferes with or inhibits the physiological action of another. Enter Naloxone, an Opioid Antagonist, and the most famous chemical antagonists of the past few years in Federal and State legislation.
